Out-of-Stock – COVID-19 – Authorisations for the temporary import and distribution of human medicines – Update
Status as of 01.06.2023
In Ordinance 3 on Measures to Combat the Coronavirus (Covid-19 Ordinance 3, SR 818.101.24), the Federal Council issues provisions designed to ensure the supply of important medical goods. Based on Art. 22 para. 3 of this ordinance, Swissmedic can approve the import of essentially identical medicinal products as a short-term solution for any temporary non-availability of medicinal products.
Medicinal products imported by hospital pharmacists under their own responsibility according to Art. 22 para. 1 of the Covid-19 Ordinance 3 are not included in this list.
The following table lists the temporary import and distribution licences granted by Swissmedic on the basis of the Covid-19 Ordinance. The goods are usually allocated and information provided on their respective availability by the department at the Federal Office of Public Health responsible for procuring medical goods.
Distribution period ongoing
Active substance |
Pharmaceutical form / Dosage |
Batch reference |
Distribution licensed until |
Casirivimab / Imdevimab |
Concentrato per soluzione per infusione, 120mg/mL |
N7601B04 |
30.06.2023
|
Propofol |
Emulsion for injection/infusion, 10 mg/ml (in a pre-filled syringe) |
RY659 |
30.06.2023 |
Distribution period elapsed: products may still be present at the dispensing outlets; dispensing and use permitted until the batches have expired
Active substance |
Pharmaceutical form / Dosage |
Batch reference |
Distribution licensed until |
Propofol |
Emulsione iniettabile/infusione, 10 mg/ml, 50ml flaconi |
K20018B |
31.12.2022 |
Remdesivir |
Powder for preparation of a solution for infusion, 100 mg |
C2000141D2 20410871D1 00009D 00009D4 00010D2 20411011M AP0083BM1 AP0425BM1 |
25.11.2022 |
Remifentanil |
Powder for preparation of a solution for infusion, 5 mg |
D38B |
31.12.2021 |
Lopinavir / Ritonavir |
Film-coated tablets, 200 mg/tab. and 50 mg/tab. |
1125683 1125601 1126558 |
31.12.2020 |
Lopinavir / Ritonavir |
Syrup, 400 mg/5 ml and 100 mg/5 ml |
6088549 |
31.12.2020 |
Midazolam |
Ampoules, 50 mg/10 ml |
F1058F02 |
31.12.2020 |